(Q77377828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

meta-analysis

0 references

title

Discontinuation rates of Helicobacter pylori treatment regimens: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

1 reference

Helicobacter pylori infectious disease

1 reference

S M Buring

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

L H Winner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R C Hatton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

P L Doering

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

324-332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Antibacterial treatment of gastric ulcers associated with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Helicobacter pyloriEradication with Doxycycline—Metronidazole—Bismuth Subcitrate Triple Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Eradication of Helicobacter pylori with lansoprazole and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Lansoprazole treatment of Helicobacter pylori-positive peptic ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Clinical efficacy of lansoprazole in eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse: comparison of 1 week and 2 week regimens and recrudescence rates over 12 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: randomized controlled study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.324.30939

10.1592/PHCO.19.4.324.30939

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10221370%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference